Bruton's Tyrosine Kinase-Mediated Signaling in Myeloid Cells Is Required for Protective Innate Immunity During Pneumococcal Pneumonia

被引:10
|
作者
de Porto, Alexander P. [1 ,2 ]
Liu, Zhe [1 ,2 ]
de Beer, Regina [1 ,2 ]
Florquin, Sandrine [3 ]
Roelofs, Joris J. T. H. [3 ]
de Boer, Onno J. [3 ]
den Haan, Joke M. M. [4 ]
Hendriks, Rudi W. [5 ]
van 't Veer, Cornelis [1 ,2 ]
van der Poll, Tom [1 ,2 ,6 ]
de Vos, Alex F. [1 ,2 ]
机构
[1] Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Acad Med Ctr, Ctr Expt & Mol Med CEMM, Amsterdam, Netherlands
[2] Amsterdam Univ Med Ctr UMC, Amsterdam Infect & Immun Inst AI&II, Amsterdam, Netherlands
[3] Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands
[4] Vrile Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands
[5] Univ Med Ctr, Erasmus Med Ctr Rotterdam, Dept Pulm Med, Rotterdam, Netherlands
[6] Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Acad Med Ctr, Div Infect Dis, Amsterdam, Netherlands
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
关键词
BTK; Bruton's tyrosine kinase; X-linked immunodeficiency; natural antibodies; Streptococcus pneumoniae; pneumonia; sepsis; myeloid cells; mice; X-LINKED AGAMMAGLOBULINEMIA; HOST-DEFENSE; STREPTOCOCCUS-PNEUMONIAE; NEUTROPHIL RECRUITMENT; ALVEOLAR MACROPHAGES; INTEGRIN ACTIVATION; TRANSGENIC MICE; BTK; EXPRESSION; DEFICIENCY;
D O I
10.3389/fimmu.2021.723967
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bruton's tyrosine kinase (Btk) is a cytoplasmic kinase expressed in B cells and myeloid cells. It is essential for B cell development and natural antibody-mediated host defense against bacteria in humans and mice, but little is known about the role of Btk in innate host defense in vivo. Previous studies have indicated that lack of (natural) antibodies is paramount for impaired host defense against Streptococcus (S.) pneumoniae in patients and mice with a deficiency in functional Btk. In the present study, we re-examined the role of Btk in B cells and myeloid cells during pneumococcal pneumonia and sepsis in mice. The antibacterial defense of Btk(-/-) mice was severely impaired during pneumococcal pneumosepsis and restoration of natural antibody production in Btk(-/-) mice by transgenic expression of Btk specifically in B cells did not suffice to protect against infection. Btk(-/-) mice with reinforced Btk expression in MhcII(+) cells, including B cells, dendritic cells and macrophages, showed improved antibacterial defense as compared to Btk(-/-) mice. Bacterial outgrowth in Lysmcre-Btk(fl)/Y mice was unaltered despite a reduced capacity of Btk-deficient alveolar macrophages to respond to pneumococci. Mrp8cre-Btk(fl)/Y mice with a neutrophil specific paucity in Btk expression, however, demonstrated impaired antibacterial defense. Neutrophils of Mrp8cre-Btk(fl)/Y mice displayed reduced release of granule content after pulmonary installation of lipoteichoic acid, a gram-positive bacterial cell wall component relevant for pneumococci. Moreover, Btk deficient neutrophils showed impaired degranulation and phagocytosis upon incubation with pneumococci ex vivo. Taken together, the results of our study indicate that besides regulating B cell-mediated immunity, Btk is critical for regulation of myeloid cell-mediated, and particularly neutrophil-mediated, innate host defense against S. pneumoniae in vivo.
引用
收藏
页数:15
相关论文
共 22 条
  • [1] Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity
    Weber, Alexander N. R.
    Bittner, Zsofia
    Liu, Xiao
    Truong-Minh Dang
    Radsak, Markus Philipp
    Brunner, Cornelia
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [2] Bruton's Tyrosine Kinase is involved in innate and adaptive immunity
    Brunner, C
    Müller, B
    Wirth, T
    HISTOLOGY AND HISTOPATHOLOGY, 2005, 20 (03) : 945 - 955
  • [3] Pirtobrutinib inhibits wild-type and mutant Bruton's tyrosine kinase-mediated signaling in chronic lymphocytic leukemia
    Aslan, Burcu
    Kismali, Gorkem
    Iles, Lakesla R.
    Manyam, Ganiraju C.
    Ayres, Mary L.
    Chen, Lisa S.
    Gagea, Mihai
    Bertilaccio, Maria Teresa Sabrina
    Wierda, William G.
    Gandhi, Varsha
    BLOOD CANCER JOURNAL, 2022, 12 (05)
  • [4] Bruton’s tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment
    Logan Good
    Brooke Benner
    William E. Carson
    Cancer Immunology, Immunotherapy, 2021, 70 : 2439 - 2451
  • [5] Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment
    Good, Logan
    Benner, Brooke
    Carson, William E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2439 - 2451
  • [6] Targeting Bruton's tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments
    Tavakoli, Gita Manzari
    Yazdanpanah, Niloufar
    Rezaei, Nima
    ADVANCES IN RHEUMATOLOGY, 2024, 64 (01):
  • [7] Bruton's tyrosine kinase is dispensable for the Toll-like receptor-mediated activation of mast cells
    Zorn, Carolin N.
    Keck, Simone
    Hendriks, Rudi W.
    Leitges, Michael
    Freudenberg, Marina A.
    Huber, Michael
    CELLULAR SIGNALLING, 2009, 21 (01) : 79 - 86
  • [8] A Novel Role for Bruton's Tyrosine Kinase in Hepatocyte Growth Factor-mediated Immunoregulation of Dendritic Cells
    Singhal, Eshu
    Kumar, Prakash
    Sen, Pradip
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (37) : 32054 - 32063
  • [9] The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation
    Stadler, Nicole
    Hasibeder, Astrid
    Lopez, Pamela Aranda
    Teschner, Daniel
    Desuki, Alexander
    Kriege, Oliver
    Weber, Alexander N. R.
    Schulz, Christoph
    Michel, Christian
    Hess, Georg
    Radsak, Markus P.
    HAEMATOLOGICA, 2017, 102 (05) : E191 - E194
  • [10] Antihistamines are synergistic with Bruton's tyrosine kinase inhibiter ibrutinib mediated by lysosome disruption in chronic lymphocytic leukemia (CLL) cells
    Chanas-Larue, Aaron
    Villalpando-Rodriguez, Gloria E.
    Henson, Elizabeth S.
    Johnston, James B.
    Gibson, Spencer B.
    LEUKEMIA RESEARCH, 2020, 96